九安医疗：考虑CGM领域协同并购实现快速增长

Core Viewpoint - The company is focused on accelerating the implementation of its "O+O" new model for diabetes diagnosis and care in China and the United States, while also aiming to develop "blockbuster products" in the CGM and internet healthcare sectors [1] Group 1: Strategic Focus - The company is committed to building a competitive edge in the Continuous Glucose Monitoring (CGM) field and is open to considering mergers and acquisitions (M&A) or strategic investments in companies with key technological capabilities [1] - The company emphasizes the importance of aligning with partners that share its business philosophy and values, indicating a cautious approach to M&A in non-core areas [1] Group 2: Market Opportunities - The company recognizes the broad prospects in its main business areas, particularly in CGM and internet healthcare, and is actively seeking suitable opportunities for growth [1] - The company acknowledges the need for patience in identifying good acquisition targets, highlighting the challenges and costs associated with entering non-core industries [1]